Role of Cemiplimab in the Neoadjuvant Setting for Patients with cSCC
Nikhil Khushalani, MD, comments on updated data evaluating the use of cemiplimab in the neoadjuvant setting for patients with cSCC.
EP: 1.Overview of Cutaneous Squamous Cell Carcinoma (cSCC)
EP: 2.Treatment Options for Patients with cSCC in the Neoadjuvant Setting
EP: 3.Current Treatment Options for Patients with Advanced Cutaneous Squamous Cell Carcinoma (cSCC)
EP: 4.Review of Updated Efficacy and Safety Data from the EMPOWER-CSCC-1 Trial
Now Viewing
EP: 5.Role of Cemiplimab in the Neoadjuvant Setting for Patients with cSCC
EP: 6.Real-World Data of Cemiplimab in Patients with Advanced cSCC
EP: 7.Investigational Agents for the Treatment of Advanced cSCC
EP: 8.An Overview of Advanced Basal Cell Carcinoma (BCC) and Currently Available Treatment Options
EP: 9.Future Perspectives in cSCC
EP: 10.Treatment Options for Patients with Advanced Basal Cell Carcinoma (BCC)
EP: 11.Looking Ahead: Unmet Needs for the Treatment of BCC
Related Videos
Related Content
